Oritavancin for hard-to-treat device infections
Part of Heart & circulation, Infections clinical trials.
This trial tests if the antibiotic oritavancin can fight stubborn infections in pacemakers or similar heart devices caused by bacteria resistant to standard treatments. It may help people who cannot take common antibiotics due to allergies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a heart device (like a pacemaker) with a skin infection or pocket infection showing redness, swelling, pus, or an open wound.
- Your infection is caused by certain resistant bacteria (Staphylococcus, Streptococcus, or Enterococcus) that respond to oritavancin.
- You are not allergic to oritavancin or similar antibiotics (unless you are in the control group).
- You agree to avoid heparin (a blood thinner) during treatment if needed.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a newer antibiotic called oritavancin to treat serious infections of the heart (such as endocarditis or infections around pacemakers). You would receive this medication while hospitalized and be monitored closely to see if it works and is safe for your condition.
This trial tests whether a treatment without rifampin works as well as one with rifampin for a type of heart valve infection caused by staph bacteria. It aims to find a simpler and safer option for patients with an infected artificial heart valve.
This trial measures how your body handles certain intravenous antibiotics used for endocarditis, an infection of the heart valves. It may help doctors understand the best antibiotic dosing for people with valve infections.
This trial tests if the antibiotic dalbavancin can effectively treat a certain type of serious heart valve infection (endocarditis) caused by specific bacteria. You may be eligible if you have this infection in your left-sided heart valves and are at least 18 years old.
This trial is testing whether a shorter course of antibiotics (instead of the usual longer course) is safe and effective for people who have had an infection on the wires of their pacemaker or defibrillator, after the device has been completely removed.
This trial tests whether putting antibiotics directly inside the bone during surgery can improve outcomes for an infected knee prosthesis when the implant is being kept. It may help more people avoid needing full implant removal and replacement.
Hear when a new Infective Endocarditis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.